e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Biomarkers of allergic inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Expresion of galectins in asthma patients
S. Sánchez-Cuéllar, H. de La Fuente, A. Lamana, D. Cibrián, A. Cruz-Adalia, R. M. Girón, F. Sánchez-Madrid, J. Ancochea (Madrid, Spain)
Source:
Annual Congress 2011 - Biomarkers of allergic inflammation
Session:
Biomarkers of allergic inflammation
Session type:
Poster Discussion
Number:
477
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Sánchez-Cuéllar, H. de La Fuente, A. Lamana, D. Cibrián, A. Cruz-Adalia, R. M. Girón, F. Sánchez-Madrid, J. Ancochea (Madrid, Spain). Expresion of galectins in asthma patients. Eur Respir J 2011; 38: Suppl. 55, 477
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Place des anti-IL5 dans les pathologies éosinophiliques (hors asthme sévère) / Anti-IL-5 therapy for indications other than severe asthma
Source: Virtual Congress 2020 – French programme 2020: Part II
Year: 2020
Régulation de l'inflammation dans l'asthme : IL37 vs IL17Inflammatory regulation in asthma: IL37 vs IL17
Source: International Congress 2017 – French Programme 2017
Year: 2017
Risques cardiovasculaires et BPCO / Cardiovascular risks and COPD
Source: Virtual Congress 2020 – French programme 2020: Part II
Year: 2020
Comparison of efficacy of grippe vaccination in asthma and COPD patients
Source: Annual Congress 2011 - Asthma: control and treatment
Year: 2011
Cost of chronic allergic rhinitis: French exemple
Source: Eur Respir J 2003; 22: Suppl. 45, 116s
Year: 2003
COPD: the Italian recommendationBPCO: le raccomandazioni Italiane
Source: International Congress 2017 – ERS Italian Day programme
Year: 2017
Prise en charge de l’aspergillose pulmonaire chronique Chronic pulmonary aspergillosis care
Source: International Congress 2017 – French Programme 2017
Year: 2017
Occupational asthma in France: a 1-yr report of the Observatoire National de Asthmes Professionnels project
Source: Eur Respir J 2002; 19: 84-89
Year: 2002
Troubles respiratoires du sommeil et cancer : données épidémiologiques / Respiratory disorders associated with sleep and cancer: epidemiological data
Source: Virtual Congress 2020 – French programme 2020: Part I
Year: 2020
Recommandations européennes ERS/ESC pour le diagnostic et la prise en charge de l’hypertension pulmonaireERS/ESC European guidelines for the diagnosis and treatment of pulmonary hypertension
Source: International Congress 2016 – ERS/French Programme II
Year: 2016
Exacerbation aiguë de la fibrose pulmonaire idiopathique: ce qu'il ne faut plus faire et ce qu'il reste à faire. / Acute exacerbation of idiopathic pulmonary fibrosis: what should not be done and what remains to be done?
Source: Virtual Congress 2021 – French programme 2021
Year: 2021
Syndrome obésité-hypoventilation: de la physiologie au traitementObesity hypoventilation: from pathophysiology to treatment
Source: International Congress 2016 – ERS/French Programme I
Year: 2016
Nouvelles perspectives thérapeutiques dans la tuberculose multi-résistanteNew perspectives in the treatment of MDR-TB
Source: International Congress 2016 – ERS/French Programme II
Year: 2016
La simvastatina no inhibe la inflamación producida por las células pulmonares
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
Mucoviscidose: enfin des traitements ciblés / Cystic fibrosis: targeted therapies, at last !
Source: Virtual Congress 2020 – French programme 2020: Part I
Year: 2020
Evolution of the psychometric dimensions of the VQ11 questionnaire in COPD patients undergoing a pulmonary rehabilitation program (PRP). Results from the French cohort Rehaeffort from IRSR des Pays de Loire
Source: International Congress 2016 – Latest insights into pulmonary rehabilitation
Year: 2016
Thermoplastie bronchique : indications actuelles / Asthma thermoplasty: current indications
Source: Virtual Congress 2021 – French programme 2021
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept